Form 4 Filing for AETHLON MEDICAL INC

Edward G. Broenniman, a director at AETHLON MEDICAL INC (AEMD), reported the acquisition of 21,815 shares of Common Stock on April 17, 2026. The shares were acquired at a price of $2.29 per share. This transaction is part of a grant of RSUs that vest in four equal quarterly installments through March 31, 2027, contingent upon continued service. Following this acquisition, Broenniman now owns 23,454 shares. The filing also notes that the transaction is not subject to Section 16 of the Securities Exchange Act of 1934.